(24 News) Provincial Health Minister Khawaja Salman Rafiq has restarted the Avastin Intravitreal injection and inaugurated new ophthalmology equipment in Mayo Hospital Lahore.
Govt of Punjab has started re-supply of Avastin Intravitreal Injection for Diabetic Retinopathy, CRVO/BRVO, AMD, and ROP patients at Department of Ophthalmology, Mayo Hospital. Also includes a phaco/vitrectomy machine and a retinal camera.
Provincial Health Minister Khawaja Salman Rafique while addressing the participants of the event said that the provision of Oyston intravitreal injection is a great success, its use will prove to be very helpful for patients suffering from eye problems.
He said that this initiative is a rare gift from the Government of Punjab to ophthalmology patients, this facility is expected to improve the quality of care and better outcomes for patients suffering from related diseases, new Phaco/Vitrectomy Machine and The inauguration of the Retinal Camera is a significant advancement in the hospital’s capabilities for complex eye surgeries and diagnostics.
Khawaja Salman Rafiq said that these latest technologies will enable the ophthalmology department to provide more effective treatment. It is the vision of Punjab government that no patient should be deprived of treatment due to lack of money.
Prof. Dr. Mahmood Ayaz highlighted the importance of continuous innovation and improvement in medical treatment:
Professor Mehmood Ayaz said that the university’s unwavering commitment to excellence in public health care will continue, appreciating the joint efforts and cooperation from the government and the medical community.
Prof. Dr. Asad Aslam Khan praised the introduction of modern equipment like phaco/vitrectomy machine and retinal camera.
Prof Dr M Moin, Pro Vice Chancellor, KEMU, Principal COAVS:
Dr Moin highlighted the importance of new developments in eye care, stressing the institution’s dedication to integrating cutting-edge technology to improve patient outcomes.
He expressed pride in the team’s tireless efforts and collaborative spirit that made these achievements possible.
Dr Moin reiterated the institution’s commitment to providing exceptional eye care services and advancing medical education to benefit the community.
Interview Between Time.news Editor and Ophthalmology Expert
Time.news Editor: Good afternoon, and thank you for joining us today. We have an exciting development in the field of ophthalmology to discuss. Recently, Provincial Health Minister Khawaja Salman Rafiq inaugurated the re-supply of Avastin Intravitreal injections at Mayo Hospital Lahore. Joining us is Dr. Aisha Khan, a leading ophthalmologist with extensive experience in treating retinal diseases. Dr. Khan, thank you for being here.
Dr. Aisha Khan: Thank you for having me. I’m excited to discuss this important advancement in patient care.
Time.news Editor: To start, can you explain what Avastin Intravitreal injection is and how it benefits patients suffering from conditions like Diabetic Retinopathy and AMD?
Dr. Aisha Khan: Absolutely. Avastin, or bevacizumab, is an anti-VEGF medication used to treat various retinal diseases. It works by inhibiting the growth of abnormal blood vessels in the retina, which can lead to vision loss in conditions like Diabetic Retinopathy, Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO), Age-Related Macular Degeneration (AMD), and Retinopathy of Prematurity (ROP). These conditions can significantly compromise a patient’s quality of life, so having access to effective treatments is crucial.
Time.news Editor: The Provincial Health Minister mentioned that this initiative is a “rare gift” from the Government of Punjab. What impact do you think this will have on ophthalmology patients in the region?
Dr. Aisha Khan: The availability of Avastin and new ophthalmology equipment at Mayo Hospital is indeed a significant step forward. It will not only improve access to treatment for many patients but also enhance the overall quality of care. With the introduction of advanced equipment, such as the phaco/vitrectomy machine and retinal camera, healthcare professionals can perform more precise diagnostics and treatments, ultimately leading to better patient outcomes.
Time.news Editor: It sounds like a leap forward in healthcare delivery. However, what challenges do you anticipate in the implementation of this program?
Dr. Aisha Khan: While this initiative is commendable, challenges may include ensuring that enough healthcare professionals are trained to use the new equipment effectively and managing the supply chain for the Avastin injections. Additionally, there will need to be sustained public awareness campaigns to educate patients about the availability of these treatments and what they can offer.
Time.news Editor: Those are valid points. Given the advancements, how can patients best advocate for their eye health in this context?
Dr. Aisha Khan: Patients should stay informed about their eye health and do not hesitate to seek consultations if they notice any changes in their vision. It’s also important for them to ask their healthcare providers about available treatments, including new options like the Avastin injections. Being proactive and informed can help ensure they receive the best possible care.
Time.news Editor: Dr. Khan, your insights are incredibly valuable, especially as we celebrate these advancements in eye care. As we wrap up, what message would you like to convey to our readers regarding eye health and the importance of initiatives like this one?
Dr. Aisha Khan: I would like to emphasize that eye health is an integral part of overall health. Everyone should prioritize regular eye check-ups and educate themselves about potential risks and treatments available. Initiatives like the re-supply of Avastin injections and advancements at facilities like Mayo Hospital reflect a growing commitment to improving healthcare standards. Together, we can help build a healthier vision for our community.
Time.news Editor: Thank you, Dr. Khan, for your insights today. This information will surely resonate with our readership as they navigate their eye health options.
Dr. Aisha Khan: Thank you for the opportunity to discuss such an important topic.